- Thinly traded nano cap Check-Cap (CHEK +11.9%) breaks out of brief consolidation on almost 60% higher volume. Shares have doubled since touching $1.62 on December 21, 2018.
- No particular news accounts for the action. Final results from a post-CE Mark study on its C-Scan colorectal cancer screening capsule should be available next quarter. A U.S. pilot study should launch as well (corporate presentation, slide #20).
- In July 2018, it filed a prospectus for a $100M shelf offering of units, warrants and subscription rights. At the end of September 2018, it had $17.6M in quick assets while operations consumed $7.3M during the first three months of the year.
Check-Cap up 12%
Recommended For You
More Trending News
About CHEK Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CHEK | - | - |
Check-Cap Ltd. |